Stories
Neuberg Diagnostics Integrates NM Medical to Expand Maharashtra Footprint Ahead of IPO
M
Moneycontrol•07-10-2026, 12:29
Neuberg Diagnostics Integrates NM Medical to Expand Maharashtra Footprint Ahead of IPO
- •Neuberg Diagnostics has consolidated Mumbai-based NM Medical into its Maharashtra operations to create an integrated diagnostics platform combining pathology, radiology, genomics and preventive healthcare.
- •The deal values NM Medical around Rs 800-850 crore with a revenue of approximately Rs 200 crore, setting the stage for Neuberg to file its DRHP and target an IPO next year.
- •The combined platform, operating under brands like Neuberg NM Medical, will be chaired by Dr Nilesh Shah, with Rahil Shah serving as CEO for Maharashtra, preventive wellness and Africa operations.
- •This consolidation follows Neuberg's strategic partnership with Mahajan Imaging & Labs to expand into North India, bolstering its national network ahead of its public market debut.
- •Neuberg also launched Atlas, a longevity and wellness initiative integrating diagnostics, imaging, genomics and personalised health insights, with its first centre at NM Medical's Marine Lines facility in Mumbai.
Key Questions Answered
NM Medical was valued at approximately Rs 800-850 crore, and it generates revenue of around Rs 200 crore.
Neuberg Diagnostics is expected to file its draft red herring prospectus (DRHP) in the next few months, aiming for a public offering next year.
The longevity and wellness initiative is named Atlas, which integrates diagnostics, imaging, genomics, and personalised health insights.
